Rachel Thompson

Rachel Thompson

Auto-generated profile, based on publicly available information

Rachel Thompson

Centre for Human Genetics, University of Oxford, Oxford, United Kingdom

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
KJKerina Jones
Kerina Jones
RTRachel Thompson
Rachel Thompson
Background: Many countries remain in the grip of the COVID-19 global pandemic, with a considerable journey still ahead toward normalcy and free mobility. Contact tracing smartphone apps are among a raft of measures introduced to reduce spread of the virus, but their uptake depends on public choice. Objective: The objective of this study was to ascertain the views of citizens in Wales on their intended use of a COVID-19 contact tracing smartphone app, including self-proposed reasons for or against use and what could lead to a change of decision. Methods: We distributed an anonymous survey among 4000 HealthWise Wales participants in May 2020. We adopted a mixed methods approach: responses to closed questions were analyzed using descriptive and inferential statistics; open question responses were analyzed and grouped into categories. Results: A total of 976 (24.4%) people completed the survey. Smartphone usage was 91.5% overall, but this varied among age groups. In total, 97.1% were aware of contact tracing apps, but only 67.2% felt sufficiently informed. Furthermore, 55.7% intended to use an app, 23.3% refused, and 21.0% were unsure. The top reasons for app use were as follows: controlling the spread of the virus, mitigating risks for others and for oneself, and increasing freedoms. The top reasons against app use were as follows: mistrusting the government, concerns about data security and privacy, and doubts about efficacy. The top response for changing one’s mind about app use from being willing to being unwilling was that nothing would; that is, they felt that nothing would cause them to become unwilling to use a contact tracing app. This was also the top response for changing one’s mind from being unwilling to being willing to use contact tracing apps. Among those who were unsure of using contact tracing apps, the top response was the need for more information. Conclusions: Respondents demonstrated a keenness to help themselves, others, society, and the government to avoid contracting the virus and to control its spread. However, digital inclusion varied among age groups, precluding participation for some people. Nonetheless, unwillingness was significant, and considering the nature of the concerns raised and the perceived lack of information, policy and decision-makers need to do more to act openly, increase communication, and demonstrate trustworthiness if members of the public are to be confident in using an app.

30 October 2019 in Public Health Ethics
Verified
Journal Article
Open access
PDF file
MSMark Sheehan
Mark Sheehan
RTRachel Thompson
Rachel Thompson
JFJon Fistein
Jon Fistein
JDJim Davies
Jim Davies
MDMichael Dunn
Michael Dunn
KWKerrie Woods
Kerrie Woods
Population-level biomedical research has become crucial to the health system’s ability to improve the health of the population. This form of research raises a number of well-documented ethical concerns, perhaps the most significant of which is the inability of the researcher to obtain fully informed specific consent from participants. Two proposed technical solutions to this problem of consent in large-scale biomedical research that have become increasingly popular are meta-consent and dynamic consent. We critically examine the ethical and practical credentials of these proposals and find them lacking. We suggest that the consent problem is not solved by adopting a technology driven approach grounded in a notion of ‘specific’ consent but by taking seriously the role of research governance in combination with broader conceptions of consent. In our view, these approaches misconstrue the rightful location of authority in the way in which population-level biomedical research activities are structured and organized. We conclude by showing how and why the authority for determining the nature and shape of choice making about participation ought not to lie with individual participants, but rather with the researchers and the research governance process, and that this necessarily leads to the endorsement of a fully articulated broad consent approach.

3 July 2021 in Javnost - The Public
Verified
Journal Article
Open access
SEStephen Elstub
Stephen Elstub
RTRachel Thompson
Rachel Thompson
OEOliver Escobar
Oliver Escobar
JHJoe Hollinghurst
Joe Hollinghurst
DGDuncan Grimes
Duncan Grimes
NSNayha Sethi
Nayha Sethi
Quality deliberation is essential for societies to address the challenges presented by the coronavirus pandemic effectively and legitimately. Critics of deliberative and participatory democracy are highly skeptical that most citizens can engage with such complex issues in good circumstances and these are far from ideal circumstances. The need for rapid action and decision-making is a challenge for inclusivity and quality of deliberation. Additionally, policy responses to the virus need to be even more co-ordinated than usual, which intensifies their complexity. The digitalisation of the public sphere may be seen as a further challenge to deliberating. Furthermore, these are stressful and emotional times, making a considered judgement on these issues potentially challenging. We employ a modified version of the Discourse Quality Index to assess the deliberative quality in two facilitated synchronous digital platforms to consider aspects of data use in light of COVID 19. Our study is the first to perform a comprehensive, systematic and in-depth analysis of the deliberative capacity of citizens in a pandemic. Our evidence indicates that deliberation can be resilient in a crisis. The findings will have relevance to those interested in pandemic democracy, deliberative democracy in a crisis, data use and digital public spheres.

14 November 2017 in BMC Genomics
Verified
Journal Article
Open access
PDF file
RTRachel Thompson
Rachel Thompson
MMMichael J. McNamee
Michael J. McNamee
This article provides a critical overview of the ethics and governance of genetic biobank research, using the Athlome Consortium as a large scale instance of collaborative sports genetic biobanking. We present a traditional model of written informed consent for the acquisition, storage, sharing and analysis of genetic data and articulate the challenges to it from new research practices such as genetic biobanking. We then articulate six possible alternative consent models: verbal consent, blanket consent, broad consent, meta consent, dynamic consent and waived consent. We argue that these models or conceptions of consent must be articulated in the context of the complexities of international legislation and non legislative national and international biobank governance frameworks and policies, those which govern research in the field of sports genetics. We discuss the tensions between individual rights and public benefits of genomic research as a critical ethical issue, particularly where benefits are less obvious, as in sports genomics. The inherent complexities of international regulation and biobanking governance are challenging in a relatively young field. We argue that there is much nuanced ethical work still to be done with regard to governance of sports genetic biobanking and the issues contained therein.

24 August 2020 in International Journal of Population Data Science
Verified
Journal Article
Open access
PDF file
KJKerina Jones
Kerina Jones
SHSharon Heys
Sharon Heys
RTRachel Thompson
Rachel Thompson
LCLynsey Cross
Lynsey Cross
DFDavid Ford
David Ford
Background: The SAIL Databank is a data safe haven established in 2007 at Swansea University (Wales). It was set up to create new opportunities for research using routinely-collected health and other public service datasets in linkable anonymised form. SAIL forms the bedrock of other Population Data Science initiatives made possible by the data and safe haven environment. Aim: The aim of this paper is to provide an overview of public involvement and engagement in connection with the SAIL Databank and related Population Data Science initiatives. Approach: We have a public involvement and engagement policy for SAIL in the context of Population Data Science. We established a Consumer Panel to provide advice on the work of SAIL and associated initiatives, including on proposed uses of SAIL data. We reviewed the topics discussed and provide examples of advice to researchers. We carried out a survey with members on their experiences of being on the Panel and their perceptions of the work of SAIL. We have a programme of wider public engagement and provide illustrations of this work. Discussion: We summarise what this paper adds and some lessons learned. In the rapidly developing area of Population Data Science it is important that people feel welcome, that they are encouraged to ask questions and are provided with digestible information and adequate consideration time. Citizens have provided us with valuable anticipated and unanticipated opinions and novel viewpoints. We seek to take a pragmatic approach, prioritising the communication modes that allow maximum public input commensurate with the purpose of the activity. Conclusion: This paper has set out our policy, rationale, scope and practical approaches to public involvement and engagement for SAIL and our related Population Data Science initiatives. Although there will be jurisdictional, cultural and organizational differences, we believe that the material covered in this paper will be of interest to other data focused enterprises across the world.

19 October 2019 in International Journal of Sport Policy and Politics
Verified
Journal Article
Closed access
EKErika Kleiderman
Erika Kleiderman
RTRachel Thompson
Rachel Thompson
PBPascal Borry
Pascal Borry
ABAudrey Boily
Audrey Boily
BKBartha Knoppers
Bartha Knoppers
Doping control is an integral part of participation in sport. It aims to protect the health of athletes and to preserve the integrity and intrinsic values associated with elite sport. The World-Anti-Doping Code applies to all participating athletes, irrespective of their legal capacity and ability to provide informed consent. As such, anti-doping rule violations and the strict liability standard apply to both minor and adult athletes. Under the current Code, minors are defined as any athlete under the age of 18, and so, their vulnerable status may not be fully considered. Participation in sport (including doping control testing) is a unilateral choice – an athlete can accept or refuse to abide by the Code – if refused, the right to compete is forfeited. This article aims to explore the need for further clarification on the new categorisation of ‘mature minor’ elite athletes in the Code. We begin by providing an overview of current doping control testing procedures and the specific issues regarding consent to sample collection under the Code’s strict liability approach with its associated sanctions. We then examine the rights of minors under the Code within the broader international legal context. We conclude with a reflection on how the notion of mature minor has been addressed elsewhere, and how this can further inform ongoing revisions of the Code. These include greater flexibility in the recognition of both contextual and certain statutory criteria.